Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.

dc.contributor.author

Xu, Xinyuan

dc.contributor.author

Qian, Danwen

dc.contributor.author

Liu, Hongliang

dc.contributor.author

Cruz, Diana

dc.contributor.author

Luo, Sheng

dc.contributor.author

Walsh, Kyle M

dc.contributor.author

Abbruzzese, James L

dc.contributor.author

Zhang, Xuefeng

dc.contributor.author

Wei, Qingyi

dc.date.accessioned

2019-05-01T13:24:49Z

dc.date.available

2019-05-01T13:24:49Z

dc.date.issued

2019-04-17

dc.date.updated

2019-05-01T13:24:48Z

dc.description.abstract

The liver kinase B1-AMP-activated protein kinase (LKB1-AMPK) pathway has been identified as a new target for cancer therapy, because it controls the glucose and lipid metabolism in response to alterations in nutrients and intracellular energy levels. In the present study, we aimed to identify genetic variants of the LKB1-AMPK pathway genes and their associations with pancreatic cancer (PanC) risk using 15 418 participants of European ancestry from two previously published PanC genome-wide association studies. We found that six novel tagging single-nucleotide polymorphisms (SNPs) (i.e, MAP2 rs35075084 T > deletion, PRKAG2 rs2727572 C > T and rs34852782 A > deletion, TP53 rs9895829 A > G, and RPTOR rs62068300 G > A and rs3751936 G > C) were significantly associated with an increased PanC risk. The multivariate logistic regression model incorporating the number of unfavorable genotypes (NUGs) with adjustment for age and sex showed that carriers with five to six NUGs had an increased PanC risk (odds ratio = 1.24, 95% confidence interval = 1.16-1.32 and P < 0.0001), compared to those with zero to four NUGs. Subsequent expression quantitative trait loci (eQTL) analysis further revealed that these SNPs were associated with significantly altered mRNA expression levels either in 373 normal lymphoblastoid cell lines (TP53 SNP rs9895829, P < 0.05) or in whole blood cells of 369 normal donors from the genotype-tissue expression project (GTEx) database [RPTOR SNP rs60268947 and rs28434589, both in high linkage disequilibrium (r2  > 0.9) withRPTOR rs62068300, P < 0.001]. Collectively, our findings suggest that these novel SNPs in the LKB1-AMPK pathway genes may modify susceptibility to PanC, possibly by influencing gene expression.

dc.identifier.issn

0899-1987

dc.identifier.issn

1098-2744

dc.identifier.uri

https://hdl.handle.net/10161/18472

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

Molecular carcinogenesis

dc.relation.isversionof

10.1002/mc.23018

dc.subject

genome-wide association study

dc.subject

pancreatic cancer risk

dc.subject

single-nucleotide polymorphism (SNP)

dc.title

Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.

dc.type

Journal article

duke.contributor.orcid

Luo, Sheng|0000-0003-4214-5809

duke.contributor.orcid

Walsh, Kyle M|0000-0002-5879-9981

duke.contributor.orcid

Wei, Qingyi|0000-0002-3845-9445|0000-0003-4115-4439

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Pathology

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Neurosurgery

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019Xu_et_al2019Molecular_Carcinogenesis_pancreatic_risk.pdf
Size:
743.08 KB
Format:
Adobe Portable Document Format
Description:
Published version